Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 68 | 108 | 102 | 301 | 88 |
| Cost of Goods | 22 | 47 | 32 | 109 | 40 |
| Gross Profit | 47 | 61 | 71 | 192 | 48 |
| Operating Expenses | 402 | 1,059 | 563 | 724 | 502 |
| Operating Income | -334 | -950 | -461 | -423 | -414 |
| Interest Expense | 8 | 60 | 97 | 83 | 82 |
| Other Income | -25 | -59 | 38 | -186 | -63 |
| Pre-tax Income | -367 | -1,069 | -521 | -692 | -558 |
| Net Income Continuous | -367 | -1,069 | -521 | -692 | -558 |
| Net Income | $-367 | $-1,069 | $-521 | $-692 | $-558 |
| EPS Basic Total Ops | -0.01 | -0.05 | -0.05 | -0.06 | -0.06 |
| EPS Basic Continuous Ops | -0.01 | -0.05 | -0.05 | -0.06 | -0.06 |
| EPS Diluted Total Ops | -0.01 | -0.05 | -0.05 | -0.06 | -0.06 |
| EPS Diluted Continuous Ops | -0.01 | -0.05 | -0.05 | -0.06 | -0.06 |
| EBITDA(a) | $-321 | $-878 | $-410 | $-542 | $-383 |